1-3 of 3
Michael S. Khodadoust
Close
Sort by
Journal Articles

Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas

Navika D. Shukla, Joseph G. Schroers-Martin, Brian J. Sworder, Karan Raj Kathuria, Stefan K. Alig, Matthew J. Frank, David B. Miklos, Steven Coutre, Maximilian Diehn, Michael S. Khodadoust, Mark Roschewski, David M. Kurtz, Ash A. Alizadeh
Journal: Blood Advances
Blood Adv (2024) 8 (3): 780–784.
https://doi.org/10.1182/bloodadvances.2023011997
Published: 2024
Journal Articles

A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis

Clinical Trials & Observations
Tanaya Shree, Sarah Haebe, Debra K. Czerwinski, Erik Eckhert, Grady Day, Anuja Sathe, Susan Grimes, Matthew J. Frank, Lauren S. Maeda, Ash A. Alizadeh, Ranjana Advani, Richard T. Hoppe, Steven R. Long, Brock Martin, Michael G. Ozawa, Michael S. Khodadoust, Hanlee P. Ji, Ronald Levy
Journal: Blood Advances
Blood Adv (2023) 8 (1): 130–142.
https://doi.org/10.1182/bloodadvances.2023011589
Published: 2023
Includes: Supplemental data
Journal Articles

Pembrolizumab in mycosis fungoides with PD-L1 structural variants

Clinical Trials & Observations
Sara Beygi, Sebastian Fernandez-Pol, George Duran, Erica B. Wang, Henning Stehr, James L. Zehnder, Nirasha Ramchurren, Steven P. Fling, Martin A. Cheever, Wen-Kai Weng, Youn H. Kim, Michael S. Khodadoust
Journal: Blood Advances
Blood Adv (2021) 5 (3): 771–774.
https://doi.org/10.1182/bloodadvances.2020002371
Published: 2021